Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Octopus Biosafety's Revenue for the
six
months ended in Dec. 2024 was €0.05 Mil. Octopus Biosafety's average Accounts Receivable for the
six
months ended in Dec. 2024 was €0.04 Mil.
Hence, Octopus Biosafety's Receivables Turnover for the
six
months ended in Dec. 2024 was 1.20.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Octopus Biosafety Receivables Turnover Related Terms
Octopus Biosafety Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Octopus Biosafety's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:OCR vs SNDK, DELL, STX: Receivables Turnover Comparison
For the Computer Hardware subindustry, Octopus Biosafety's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Octopus Biosafety Receivables Turnover vs Hardware Industry
For the Hardware industry and Technology sector, Octopus Biosafety's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Octopus Biosafety's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Octopus Biosafety (STU:OCR) has a Receivables Turnover of 1.20 as of Dec. 2024. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Octopus Biosafety and its competitors. According to the industry distribution chart, Octopus Biosafety ranks #2372 out of 2470 companies in the Hardware industry, placing it in the top 96%.
Is Octopus Biosafety's Receivables Turnover too high?
Octopus Biosafety's current Receivables Turnover is 1.20. The Hardware industry median Receivables Turnover is 4.89. Octopus Biosafety's value of 1.20 is 75.5% below this industry median. Based on the distribution chart, Octopus Biosafety ranks #2372 out of 2470 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Octopus Biosafety has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Receivables Turnover compare to SNDK and DELL?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #2372 out of 2470 companies for Receivables Turnover. This places Octopus Biosafety in the lower half of its industry. The industry median Receivables Turnover is 4.89. Octopus Biosafety's value of 1.20 is 75.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Hardware company?
The median Receivables Turnover among Hardware companies is 4.89, based on 2,470 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Octopus Biosafety's current Receivables Turnover of 1.20 is 75.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median Receivables Turnover is 4.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current Receivables Turnover is 1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Receivables Turnover of 1.20. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current Receivables Turnover is 1.20 and 75.5% below the Hardware industry median of 4.89. Octopus Biosafety's overall GF Score™ is 1/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Receivables Turnover is 1.20 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Octopus Biosafety (STU:OCR) Overvalued in 2026?
Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued.
The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.
Key valuation signals for STU:OCR:
Receivables Turnover: 1.20
GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
Industry Position: 75.5% below the Hardware median (#2372 of 2470)
No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
1GF Score
Get the complete analysis for STU:OCR
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OCR has been successfully added to your 
